Patient Reported Outcomes (PROs) in Inflammatory Bowel Disease (IBD) around the World
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 80
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are thrilled to announce a call for manuscripts on the compelling topic of “Patient Reported Outcomes (PROs) in Inflammatory Bowel Disease (IBD) around the World” for publication in our journal. As the field of IBD research continues to evolve, there is a growing recognition of the importance of incorporating patient perspectives and experiences into clinical care and research.
Patient Reported Outcomes (PROs) offer invaluable insights into the real-world impact of IBD on individuals’ lives, encompassing aspects such as symptom burden, quality of life, treatment satisfaction, and functional status. Understanding PROs is crucial for optimizing patient-centered care, enhancing treatment decision-making, and evaluating the effectiveness of interventions across diverse populations and healthcare settings.
We invite submissions that explore various dimensions of PROs in IBD, including, but not limited to, the following:
- Which PROs are routinely used in IBD?
- How is PRO reporting implemented in daily clinical routine?
- Best practice solutions for PRO reporting in different regions/countries.
- What are the strategies to implement patients’ views on therapeutic approaches?
- Which PROs reflect the psychosocial impact that IBD is having on QOL?
- Which diversity aspects are recognized in PRO reporting?
Dr. Irina Blumenstein
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- patient reported outcomes
- symptom burden
- quality of life
- treatment satisfaction
